Literature DB >> 34974120

Microbial pathogenesis in inflammatory bowel diseases.

Sunil Kumar1, Awanish Kumar2.   

Abstract

Inflammatory bowel disease (IBD) is a chronic inflammatory condition of the gastrointestinal system. Previously, it is considered the disease of the western world but now the incidence and prevalence of IBD are increasing globally with urbanization and modernization. Additionally, the major problem is the highest incidence of IBD among children and adolescents. The precise etiology of IBD is unknown and there is no cure for IBD, which is also the reason for increasing the number of cases worldwide. The IBD is a complex interplay of environment, immune system, and microbiota in a genetically susceptible host. Among these factors, the alteration in intestinal microbiota has been detected in IBD patients. The bacterial species associated with IBD include Mycobacterium paratuberculosis, adherent-invasive E. coli (AIEC), Helicobacter pylori, and Campylobacter concisus. Moreover, the efficacy of antibiotics and probiotics further suggests the role of microbes in IBD. However, no study confirmed the bacterial species as a cause of IBD as per Koch's postulates. Thus, still controversies exist regarding the role of microbes in IBD. Therefore, this paper aims to review the current literature to evaluate the role of microbes in IBD that would be a useful inventory of researchers working in this area.
Copyright © 2021 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Dysbiosis; Immune system; Inflammatory bowel disease; Microbiome; Pathogenesis

Mesh:

Year:  2021        PMID: 34974120     DOI: 10.1016/j.micpath.2021.105383

Source DB:  PubMed          Journal:  Microb Pathog        ISSN: 0882-4010            Impact factor:   3.738


  5 in total

Review 1.  Where Do We Stand in the Behavioral Pathogenesis of Inflammatory Bowel Disease? The Western Dietary Pattern and Microbiota-A Narrative Review.

Authors:  Iwona Krela-Kaźmierczak; Oliwia Zakerska-Banaszak; Marzena Skrzypczak-Zielińska; Liliana Łykowska-Szuber; Aleksandra Szymczak-Tomczak; Agnieszka Zawada; Anna Maria Rychter; Alicja Ewa Ratajczak; Kinga Skoracka; Dorota Skrzypczak; Emilia Marcinkowska; Ryszard Słomski; Agnieszka Dobrowolska
Journal:  Nutrients       Date:  2022-06-17       Impact factor: 6.706

Review 2.  Dysbiosis in Inflammatory Bowel Disease: Pathogenic Role and Potential Therapeutic Targets.

Authors:  Patricia Teixeira Santana; Siane Lopes Bittencourt Rosas; Beatriz Elias Ribeiro; Ygor Marinho; Heitor S P de Souza
Journal:  Int J Mol Sci       Date:  2022-03-23       Impact factor: 5.923

Review 3.  Immunology of Inflammatory Bowel Disease: Molecular Mechanisms and Therapeutics.

Authors:  Quan Lu; Mei-Feng Yang; Yu-Jie Liang; Jing Xu; Hao-Ming Xu; Yu-Qiang Nie; Li-Sheng Wang; Jun Yao; De-Feng Li
Journal:  J Inflamm Res       Date:  2022-03-12

Review 4.  Targeting Ferroptosis in Colorectal Cancer.

Authors:  Xiaojie Liang; Zhihuan You; Xinhao Chen; Jun Li
Journal:  Metabolites       Date:  2022-08-12

5.  Shotgun metagenomics of fecal samples from children in Peru reveals frequent complex co-infections with multiple Campylobacter species.

Authors:  Craig T Parker; Francesca Schiaffino; Steven Huynh; Maribel Paredes Olortegui; Pablo Peñataro Yori; Paul F Garcia Bardales; Tackeshy Pinedo Vasquez; Greisi E Curico Huansi; Katia Manzanares Villanueva; Wagner V Shapiama Lopez; Kerry K Cooper; Margaret N Kosek
Journal:  PLoS Negl Trop Dis       Date:  2022-10-04
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.